Source: Annals of hepatology. Unidade: FM
Subjects: POLIMORFISMO, FATORES DE RISCO, CIRROSE HEPÁTICA, FÍGADO GORDUROSO, FOSFOLIPASES, PROTEÍNAS DA MEMBRANA, ESTUDOS TRANSVERSAIS, ESTUDOS MULTICÊNTRICOS
ABNT
MAZO, Daniel F et al. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population. Annals of hepatology, v. 18, n. 3, p. 466-471, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.aohep.2018.10.004. Acesso em: 27 dez. 2024.APA
Mazo, D. F., Malta, F. M., Stefano, J. T., Salles, A. P. M., Gomes-gouvea, M. S., Nastri, A. C. S., et al. (2019). Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population. Annals of hepatology, 18( 3), 466-471. doi:10.1016/j.aohep.2018.10.004NLM
Mazo DF, Malta FM, Stefano JT, Salles APM, Gomes-gouvea MS, Nastri ACS, Almeida JR, Pinho JRR, Carrilho FJ, Oliveira CPMS de. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population [Internet]. Annals of hepatology. 2019 ; 18( 3): 466-471.[citado 2024 dez. 27 ] Available from: https://doi.org/10.1016/j.aohep.2018.10.004Vancouver
Mazo DF, Malta FM, Stefano JT, Salles APM, Gomes-gouvea MS, Nastri ACS, Almeida JR, Pinho JRR, Carrilho FJ, Oliveira CPMS de. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population [Internet]. Annals of hepatology. 2019 ; 18( 3): 466-471.[citado 2024 dez. 27 ] Available from: https://doi.org/10.1016/j.aohep.2018.10.004